Stevioside ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by downregulating the NF-κB pathway

Biochemical and Biophysical Research Communications

Volumn 417, Issue 4, 2012, Pages 1280-1285

  Wang, Zhiquan ^a   Xue, Liqiong ^a   Guo, Cuicui ^a   Han, Bing ^a   Pan, Chunming ^a   Zhao, Shuangxia ^a   Song, Huaidong ^a   Ma, Qinyun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adipose tissue; High fat diet; Inflammation; Insulin resistance; NF B pathway; Stevioside

Indexed keywords

CD14 ANTIGEN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; STEVIOSIDE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; CYTOKINES; DIET, HIGH-FAT; DITERPENES, KAURANE; DOWN-REGULATION; GLUCOSE TOLERANCE TEST; GLUCOSIDES; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; RNA, MESSENGER; SWEETENING AGENTS;

MUS;

EID: 84863044840     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.130     Document Type: Article

References (35)

1. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115:1111-1119.
2. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11:98-107.
3. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006, 6:772-783.
4. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11:85-97.
5. Chatsudthipong V., Muanprasat C. Stevioside and related compounds: therapeutic benefits beyond sweetness. Pharmacol. Ther. 2009, 121:41-54.
6. Brahmachari G., Mandal L.C., Roy R., Mondal S., Brahmachari A.K. Stevioside and related compounds - molecules of pharmaceutical promise: a critical overview. Arch. Pharm. (Weinheim) 2011, 344:5-19.
7. Jeppesen P.B., Gregersen S., Alstrup K.K., Hermansen K. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats. Phytomedicine 2002, 9:9-14.
8. Jeppesen P.B., Gregersen S., Rolfsen S.E., Jepsen M., Colombo M., Agger A., Xiao J., Kruhoffer M., Orntoft T., Hermansen K. Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism 2003, 52:372-378.
9. Chang J.C., Wu M.C., Liu I.M., Cheng J.T. Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats. Horm. Metab. Res. 2005, 37:610-616.
10. Lailerd N., Saengsirisuwan V., Sloniger J.A., Toskulkao C., Henriksen E.J. Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle. Metabolism 2004, 53:101-107.
11. Raskovic A., Mikov M., Skrbic R., Jakovljevic V., Vasovic V., Posa M., Kuhajda K., Kevresan S., Tomic Z., Siladji D. Effect of stevioside and sodium salt of monoketocholic acid on glycemia in normoglycemic and diabetic rats. Eur. J. Drug. Metab. Pharmacokinet. 2008, 33:17-22.
12. Geeraert B., Crombe F., Hulsmans M., Benhabiles N., Geuns J.M., Holvoet P. Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice. Int. J. Obes. (Lond) 2010, 34:569-577.
13. Chen T.H., Chen S.C., Chan P., Chu Y.L., Yang H.Y., Cheng J.T. Mechanism of the hypoglycemic effect of stevioside, a glycoside of Stevia rebaudiana. Planta Med. 2005, 71:108-113.
14. Ayala J.E., Bracy D.P., McGuinness O.P., Wasserman D.H. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 2006, 55:390-397.
15. Sylvetsky A., Rother K.I., Brown R. Artificial sweetener use among children: epidemiology, recommendations, metabolic outcomes, and future directions. Pediatr. Clin. North Am. 2011, 58:1467-1480.
16. Merat S., Casanada F., Sutphin M., Palinski W., Reaven P.D. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1223-1230.
17. Cole B.K., Keller S.R., Wu R., Carter J.D., Nadler J.L., Nunemaker C.S. Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice. Hypertension 2010, 55:715-721.
18. Winzell M.S., Ahren B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004, 53 (3):S215-S219.
19. Dobrian A.D., Ma Q., Lindsay J.W., Leone K.A., Ma K., Coben J., Galkina E.V., Nadler J.L. Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E410-E421.
20. Kizaki T., Maegawa T., Sakurai T., Ogasawara J.E., Ookawara T., Oh-ishi S., Izawa T., Haga S., Ohno H. Voluntary exercise attenuates obesity-associated inflammation through ghrelin expressed in macrophages. Biochem. Biophys. Res. Commun. 2011, 413:454-459.
21. Deng Y., Scherer P.E. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann. N Y Acad. Sci. 2010, 1212:E1-E19.
22. Boonkaewwan C., Toskulkao C., Vongsakul M. Anti-inflammatory and immunomodulatory activities of stevioside and its metabolite steviol on THP-1 cells. J. Agric. Food Chem. 2006, 54:785-789.
23. Boonkaewwan C., Ao M., Toskulkao C., Rao M.C. Specific immunomodulatory and secretory activities of stevioside and steviol in intestinal cells. J. Agric. Food Chem. 2008, 56:3777-3784.
24. Stoyanova S., Geuns J., Hideg E., Van Den Ende W. The food additives inulin and stevioside counteract oxidative stress. Int. J. Food Sci. Nutr. 2011, 62:207-214.
25. Mlinar B., Marc J. Review: New insights into adipose tissue dysfunction in insulin resistance. Clin. Chem. Lab. Med. 2011.
26. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116:1494-1505.
27. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
28. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.
29. Lumeng C.N., Deyoung S.M., Bodzin J.L., Saltiel A.R. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56:16-23.
30. Westerbacka J., Corner A., Kolak M., Makkonen J., Turpeinen U., Hamsten A., Fisher R.M., Yki-Jarvinen H. Insulin regulation of MCP-1 in human adipose tissue of obese and lean women. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E841-E845.
31. Lumeng C.N., Saltiel A.R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 2011, 121:2111-2117.
32. Chiang S.H., Bazuine M., Lumeng C.N., Geletka L.M., Mowers J., White N.M., Ma J.T., Zhou J., Qi N., Westcott D., Delproposto J.B., Blackwell T.S., Yull F.E., Saltiel A.R. The protein kinase IKKepsilon regulates energy balance in obese mice. Cell 2009, 138:961-975.
33. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 11:191-198.
34. Zhang J., Henagan T.M., Gao Z., Ye J. Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation. Endocrinology 2011, 152:1829-1838.
35. Chung S., Brown J.M., Provo J.N., Hopkins R., McIntosh M.K. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J. Biol. Chem. 2005, 280:38445-38456.